Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

Topo II & pol II

Jonathan B Weitzman

Author Affiliations

Genome Biology 2001, 2:spotlight-20011003-01  doi:10.1186/gb-spotlight-20011003-01

The electronic version of this article is the complete one and can be found online at:


Published:3 October 2001

© 2001 BioMed Central Ltd

Research news

The core RNA polymerase II (pol II) requires components of the holoenzyme (holo-pol) complex to drive transcription from chromatin templates. In the September 27 Nature, Neelima Mondal and Jeffrey Parvin from the Brigham and Women's Hospital, Boston, USA, report that DNA topoisomerase II alpha (topo II) is required for chromatin-dependent coactivation (Nature 2001, 413:435-438). They demonstrated that topo II is a component of the holo-pol complex and confered the ability to relax supercoiled DNA. Topo II inhibitors, such as etoposide, prevented pol II transcription on chromatin templates. The authors suggest that an additional factor is important for loading topo II onto pre-formed chromatin templates. They propose a model in which topo II is required to relieve superhelical tension generated during transcription by pol II.

References

  1. An RNA polymerase II holoenzyme responsive to activators.

    PubMed Abstract | Publisher Full Text OpenURL

  2. [http://www.nature.com] webcite

    Nature

  3. [http://www.brighamandwomens.org/] webcite

    Brigham and Women's Hospital

  4. Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase.

    PubMed Abstract OpenURL